BCMA-targeting Bispecifics in the Treatment of R/R Multiple Myeloma

Shaji Kumar, MD, presents the case of a 63-year-old woman with R/R multiple myeloma and discusses how recent data updates of bispecifics influence treatment decision-making for patients.